Historical overview of the interleukin-6 family cytokine
Open accessThe DOI matches its Crossref record; 103 of the 105 references it cites were found in a registry or an index.
Abstract
Interleukin-6 (IL-6) has been identified as a 26-kD secreted protein that stimulates B cells to produce antibodies. Later, IL-6 was revealed to have various functions that overlap with other IL-6 family cytokines and use the common IL-6 signal transducer gp130. IL-6 stimulates cells through multiple pathways, using both membrane and soluble IL-6 receptors. As indicated by the expanding market for IL-6 inhibitors, it has become a primary therapeutic target among IL-6 family cytokines. Here, we revisit the discovery of IL-6; discuss insights regarding the roles of this family of cytokines; and highlight recent advances in our understanding of regulation of IL-6 expression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1. Receptor composition of IL-6 family cytokines. IL-6 family cytokines use gp130 to transduce their signals through gp130 homodimers or gp130-containing heterodimers. IL-6, IL-11, CNTF, CLCF1, and CLCF1/CLF require binding of their nonsignaling receptor to transduce signals. A new group of members (IL-27, IL-35, and IL-39) are heterodimeric cytokines: IL-27 consists of IL-27/p28 (IL-27α) and EBI3 (also known as IL-27β); in conformity to IL-12 containing IL-12p40 (IL-12α) and IL-12p35 (IL-12β), IL-23 (IL-23p19 [IL-23α] and IL-23p40 [IL-23β]), IL-35 (IL-23p40 and EBI3), and IL-39 (IL-23p19 and EBI3; Hunter, 2005; Ning-Wei, 2010; Wang et al., 2016a). These new members activate heterodimers of gp130. IL-6R exerts its biological effects via three different signaling modes. IL-6R expression is restricted to hepatocytes and several types of immune cells, whereas gp130 is ubiquitously expressed, reflecting the diverse roles of IL-6. In the classical mode of IL-6 signaling, the cytokine interacts with mIL-6R in cells that also express gp130 (Hunter and Jones, 2015). IL-6 also binds soluble IL-6R (sIL-6R), which is shed from cells following cleavage by ADAM metalloprotease 17 (ADAM17), and is also created by alternative mRNA splicing (Lust et al., 1992). The IL-6–sIL-6R complex binds to gp130, forming a dimer that initiates intracellular signaling, a process referred to as trans-signaling. Recently, a third mode of IL-6 signaling was identified: IL-6 trans-presentation (Heink et al., 2017). This mode is specific to dendritic cells, in which the IL-6–mIL-6R complex is presented to gp130 expressed on T cells to prime pathogenic Th17 cells. These alternative modes of IL-6 signaling contribute to multiple cellular processes.](https://figures.cochat.ai/paper-figures/0d0052256f4b4b9dbf5a3cb45efbedda/historical-overview-of-the-interleukin-6-family-cytokine-figure-1.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The increased Tag+ T cell effector responses in sgBaat were also accompanied by an increase in both CD4+ T cells and natural killer cells and elevated proinflammatory cytokines [interleukin-12 (IL-12), tumor necrosis factor (TNF), IFN-γ, IL-15, IL-7] and decreased tumor-promoting cytokines such as IL-6, leukemia inhibitory factor, and IL-11 within the liver microenvironment (Fig. 2D and figs. S3,”
From Bile acid synthesis impedes tumor-specific T cell responses during liver cancer (2025) · cites this paper as [24]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Principles of interleukin (IL)-6-type cytokine signalling and its regulation
HEINRICH, P. C., BEHRMANN, I., HAAN, S., HERMANNS, H. M., MÜLLER-NEWEN, G., & SCHAPER, F. (2003) · Biochemical Journal · doi:10.1042/bj20030407 · Cited by 3,272
IL-6 as a keystone cytokine in health and disease
Hunter, C. A., & Jones, S. A. (2015) · Nature Immunology · doi:10.1038/ni.3153 · Cited by 2,511
Hirano, T., Yasukawa, K., Harada, H., Taga, T., Watanabe, Y., Matsuda, T., Kashiwamura, S.-I., Nakajima, K., Koyama, K., Iwamatsu, A., et al. (1986) · Nature · doi:10.1038/324073a0 · Cited by 2,139
Self-citationKishimoto, T. (1989) · Blood · doi:10.1182/blood.v74.1.1.1 · Cited by 2,069
Self-citationStructural design and molecular evolution of a cytokine receptor superfamily.
Bazan, J. F. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.18.6934 · Cited by 2,069
The inhibitory cytokine IL-35 contributes to regulatory T-cell function
Collison, L. W., Workman, C. J., Kuo, T. T., Boyd, K., Wang, Y., Vignali, K. M., Cross, R., Sehy, D., Blumberg, R. S., & Vignali, D. A. A. (2007) · Nature · doi:10.1038/nature06306 · Cited by 2,066
Gauldie, J., Richards, C., Harnish, D., Lansdorp, P., & Baumann, H. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.20.7251 · Cited by 1,635
Pflanz, S., Timans, J. C., Cheung, J., Rosales, R., Kanzler, H., Gilbert, J., Hibbert, L., Churakova, T., Travis, M., Vaisberg, E., et al. (2002) · Immunity · doi:10.1016/s1074-7613(02)00324-2 · Cited by 1,462
Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130
Taga, T., Hibi, M., Hirata, Y., Yamasaki, K., Yasukawa, K., Matsuda, T., Hirano, T., & Kishimoto, T. (1989) · Cell · doi:10.1016/0092-8674(89)90438-8 · Cited by 1,396
Self-citation(2012) · The Lancet · doi:10.1016/s0140-6736(12)60110-x · Cited by 1,146
Cited by
Items 101–200 of 389
Ren, Y., Guo, W., & Qiao, B. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e20175 · Cited by 17
Perugini, J., Mercurio, E. D., Giuliani, A., Sabbatinelli, J., Bonfigli, A. R., Tortato, E., Severi, I., Cinti, S., Olivieri, F., le Roux, C. W., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-11942-x · Cited by 17
Zhou, Y., Stevis, P. E., Cao, J., Ehrlich, G. K., Jones, J. L., Rafique, A., Sleeman, M. W., Olson, W. C., & Franklin, M. C. (2024) · Nature Communications · doi:10.1038/s41467-024-54124-1 · Cited by 16
Stoecklein, V. M., Wunderlich, S., Papazov, B., Thon, N., Schmutzer-Sondergeld, M., Schinner, R., Zimmermann, H., Liebig, T., Ricke, J., Liu, H., et al. (2023) · American Journal of Neuroradiology · doi:10.3174/ajnr.a7915 · Cited by 19
Mahmoudi, A. A., Heydari, S., Markina, Y. V., Barreto, G. E., & Sahebkar, A. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113304 · Cited by 16
The present roles and future perspectives of Interleukin-6 in biliary tract cancer
Zhou, M., Na, R., Lai, S., Guo, Y., Shi, J., Nie, J., Zhang, S., Wang, Y., & Zheng, T. (2023) · Cytokine · doi:10.1016/j.cyto.2023.156271 · Cited by 17
Inflammatory factors collaboratively link Helicobacter pylori-induced gastritis to gastric cancer
Zhang, M., Su, A., Song, H., Zhang, S., Deng, Y., Jing, W., Guo, J., Zhan, W., Ma, Y., & Hu, M. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1628543 · Cited by 20
Giacco, A., Petito, G., Silvestri, E., Scopigno, N., Vigliotti, M., Mercurio, G., de Lange, P., Lombardi, A., Moreno, M., Goglia, F., et al. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1432819 · Cited by 16
Kiatsoonthon, K., Phimthong, N., Potikanond, S., Wikan, N., & Nimlamool, W. (2024) · Biomolecules · doi:10.3390/biom15010034 · Cited by 15
Assessing Biomarkers in Viral Infection
Mayne, E. S., George, J. A., & Louw, S. J. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-28012-2_8 · Cited by 16
Influence of polymorphic variations of IFNL, HLA, and IL-6 genes in severe cases of COVID-19
Araújo, A., Sgorlon, G., Aguiar, L. E., CIDRÃO, M. H. M. C., Teixeira, K. S., Salcêdo, J. M. V., Passos-Silva, A. M., & Vieira, D. (2023) · Experimental Biology and Medicine · doi:10.1177/15353702231181343 · Cited by 15
The biology of interleukin-6 family cytokines is regulated by glycosylation
Kohrs, L., Buettner, F. F. R., Lokau, J., & Garbers, C. (2025) · Biochemical Journal · doi:10.1042/bcj20240769 · Cited by 14
Schumacher, N., Thomsen, I., Brundert, F., Hejret, V., Düsterhöft, S., Tichý, B., Schmidt‐Arras, D., Voß, M., & Rose‐John, S. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2023.119489 · Cited by 14
Biomarkers in immunology: Their impact on immune function and response
Kaushik, D., Xu, B., & Kumar, M. (2025) · Advances in Biomarker Sciences and Technology · doi:10.1016/j.abst.2025.03.001 · Cited by 20
NOTCH Activation via gp130/STAT3 Signaling Confers Resistance to Chemoradiotherapy
Koerdel, K., Spitzner, M., Meyer, T., Engels, N., Krause, F., Gaedcke, J., Conradi, L., Haubrock, M., Beißbarth, T., Leha, A., et al. (2021) · Cancers · doi:10.3390/cancers13030455 · Cited by 17
Liu, J., Wang, T., Yang, F., & Pubu, C. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1642436 · Cited by 15
Yu, J., Qi, J., Kong, X., & Feng, Y. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107966 · Cited by 16
Wang, X., Song, X., Fang, K., & Chang, X. (2024) · Scientific Reports · doi:10.1038/s41598-024-79008-8 · Cited by 15
Yang, T., Yang, X., Wang, G., Jia, D., & Li, Y. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114400 · Cited by 13
Coleman, L. J., Byrne, J. L., Edwards, S., & O’Hara, R. (2025) · Biologics · doi:10.3390/biologics5030027 · Cited by 15
Acute Changes in Interleukin-6 Level During Four Days of Long-Distance Walking
Soares, V., de Avelar, I. S., Venâncio, P. E. M., Pires-Oliveira, D. A. D. A., Silva, P. H. D. A., Borges, A. R., Fonseca, G. P. E. F., & Noll, M. A. (2020) · Journal of Inflammation Research · doi:10.2147/jir.s281113 · Cited by 13
Vīksne, R. J., Sumeraga, G., & Pilmane, M. (2022) · Advances in respiratory medicine · doi:10.3390/arm90050053 · Cited by 13
Zhao, Z., Li, Y., Chi, F., Ma, L., Li, Y., Hou, Z., & Wang, Q. (2022) · Aging · doi:10.18632/aging.204461 · Cited by 15
Exploring the landscape of synthetic IL ‐6‐type cytokines
Scheller, J., Ettich, J., Wittich, C., Pudewell, S., Floss, D. M., & Rafii, P. (2023) · FEBS Journal · doi:10.1111/febs.16909 · Cited by 13
Interleukin 6 Inhibition in Rheumatoid Arthritis: Highlight on Olokizumab
Feist, E., & Nasonov, E. L. (2023) · touchREVIEWS in RMD · doi:10.17925/rmd.2023.2.1.17 · Cited by 13
Chen, Y., van Zon, S., Adams, A. T., Schmidt‐Arras, D., Laurence, A. D. J., & Uhlig, H. H. (2023) · Journal of Clinical Immunology · doi:10.1007/s10875-023-01603-7 · Cited by 14
Immunosuppressive role of BDNF in therapy‐induced neuroendocrine prostate cancer
Liu, Y., Chen, W., Liu, M., Yeh, H., Chen, W., Jiang, K.-C., Li, H., Chen, Z., Wang, W., Abou-Kheir, W. G., et al. (2024) · Molecular Oncology · doi:10.1002/1878-0261.13614 · Cited by 13
Zheng, J., Li, B., Yan, Y., Huang, X., & Zhang, E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010444 · Cited by 13
Chen, M., Wan, Q., Xu, M. J., Chen, Z., & Guo, S. (2024) · Marine Biotechnology · doi:10.1007/s10126-024-10298-9 · Cited by 12
The Protective Effect of Vitexin on Hypertensive Nephropathy Rats
Duan, T., Li, M., Lin, Z., Meng, L., Li, M., Xia, T., Zhang, X., Lin, G., Yan, L., Liang, M., et al. (2024) · Kidney & Blood Pressure Research · doi:10.1159/000540618 · Cited by 12
Research Progress on the Immune Function of Liver Sinusoidal Endothelial Cells in Sepsis
Wang, X., Guo, Z., Xia, Y., Wang, X., & Wang, Z. (2025) · Cells · doi:10.3390/cells14050373 · Cited by 15
Liu, X., Li, Z., Xie, H., Cui, S., Li, X., Lang, M., Liu, M., & Shi, L. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114474 · Cited by 12
Sánchez, S. S., Quevedo, R. G., Fernandes, T. M., & da Fonseca, G. W. P. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1618360 · Cited by 14
Should We Interfere with the Interleukin-6 Receptor During COVID-19: What Do We Know So Far?
Plocque, A., Mitri, C., Lefèvre, C., Tabary, O., Touqui, L., & Philippart, F. (2022) · Drugs · doi:10.1007/s40265-022-01803-2 · Cited by 14
Xie, X., Lou, H., Shi, Y., Gan, G., Deng, H., Ma, X., Meng, M., & Gao, X. (2023) · Medicine · doi:10.1097/md.0000000000033727 · Cited by 13
Wu, B., Lan, X., Chen, X., Wu, Q., Yang, Y., & Wang, Y. (2023) · Medicine · doi:10.1097/md.0000000000034476 · Cited by 13
The deleterious impact of exposure to different inhaled anesthetics is time dependent
Júnior, P. A. M., de Souza, A. B. F., Castro, T. D. F., Perucci, L. O., Talvani, A., Cangussú, S. D., & Bezerra, F. S. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.121004 · Cited by 12
Plasma protein alterations during human large vessel stroke: A controlled comparison study
Hazelwood, H. S., Frank, J. A., Maglinger, B., McLouth, C. J., Trout, A. L., Turchan-Cholewo, J. T., Stowe, A. M., Pahwa, S. S., Dornbos, D., Fraser, J. F., et al. (2022) · Neurochemistry International · doi:10.1016/j.neuint.2022.105421 · Cited by 12
Li, D.-D., Li, N., Cai, C., Wei, C.-M., Liu, G., Wang, T., & Xu, F. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1134408 · Cited by 12
Li, B., Dong, B., Xie, L., & Li, Y. (2025) · International Journal of General Medicine · doi:10.2147/ijgm.s493021 · Cited by 11
Pan, Y., Liu, Z., Lu, J., Quan, J., Zhao, G., Song, G., Wang, J., & Ren, Z. (2025) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2025.110180 · Cited by 11
Li, F., Chen, J., Li, Y., Wang, W., Yang, Y., Wang, J., Han, M., Wang, H., Zhou, F., Ma, W., et al. (2025) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2025-013175 · Cited by 11
Wang, X., Wang, J., Wang, Q., Ding, G., Huang, Y., & Feng, Y. (2026) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-026-03656-z · Cited by 12
Gao, Q., Yin, X., Tan, B., Wang, J., Chen, J., Zhao, B., Yang, Q., & Li, Z. (2022) · BMC Infectious Diseases · doi:10.1186/s12879-022-07896-0 · Cited by 11
Xiao, R., Gu, L., Li, A.-M., Gan, Y., He, C.-Y., Liao, J., Li, Y., Xu, L., & Guo, S. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2023.119438 · Cited by 11
Liu, J., Chen, B., Lu, H., Chen, Q., & Li, J. (2023) · Clinica Chimica Acta · doi:10.1016/j.cca.2023.117506 · Cited by 14
Jiang, G., Liu, W. L., Wang, X., Wang, Z., Song, C., Chen, R., Zhao, H., Li, H., Zheng, M., & Mao, W. (2023) · Cytokine · doi:10.1016/j.cyto.2023.156470 · Cited by 11
Weitz, H. T., Ettich, J., Rafii, P., Wittich, C., Schultz, L., Frank, N. C., Heise, D., Krusche, M., Lokau, J., Garbers, C., et al. (2024) · FEBS Journal · doi:10.1111/febs.17309 · Cited by 11
Role of IL-6–IL-27 Complex in Host Antiviral Immune Response
Zuo, Q., Cheng, Z., Zhang, G., Xia, Y., Xu, G., Cao, W., Yang, X., Fu, Y.-D., He, R., Fang, P., et al. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2100179 · Cited by 11
Biomarkers in Liquid Biopsies for Prediction of Early Liver Metastases in Pancreatic Cancer
Mehdorn, A., Gemoll, T., Busch, H. S., Kern, K., Beckinger, S., Daunke, T., Kahlert, C., Uzunoglu, F. G., Hendricks, A., Bürtin, F., et al. (2022) · Cancers · doi:10.3390/cancers14194605 · Cited by 10
Zhang, F., Wang, Y., Li, H., Li, L., Yang, X., You, X., & Tang, L. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1118906 · Cited by 10
Assessment of the Effect on Periodontitis of Antibiotic Therapy and Bacterial Lysate Treatment
Ancuța, D.-L., Alexandru, D. M., Муселин, Ф., Cristina, R. T., & Coman, C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25105432 · Cited by 10
Yoshikawa, K., Kiyoshima, C., Hirakawa, T., Urushiyama, D., Fukagawa, S., Izuchi, D., Sanui, A., Kurakazu, M., Miyata, K., Nomiyama, M., et al. (2021) · Placenta · doi:10.1016/j.placenta.2021.08.059 · Cited by 10
Targeting STAT3 Signaling Facilitates Responsiveness of Pancreatic Cancer Cells to Chemoradiotherapy
Flebbe, H., Spitzner, M., Marquet, P. E., Gaedcke, J., Ghadimi, Β. M., Rieken, S., Schneider, G., König, A. O., & Grade, M. (2022) · Cancers · doi:10.3390/cancers14051301 · Cited by 11
Serum Interleukin-6 as an Early Indicator of Trauma Complications
Laishram, A., Ruram, A. A., Borgohain, B., & Laishram, K. (2024) · Cureus · doi:10.7759/cureus.68606 · Cited by 9
Advances in Interleukin-6 Family Cytokines and the Role in Respiratory Diseases
Ji, T., Huang, G., Cao, Y., Gao, Y., & Gao, X. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s508031 · Cited by 11
Shen, X., Shu, W., Zhang, J., Zhou, T., Dong, K., Zhang, J., Yao, Y., Li, H., Cheng, S., Zhang, T., et al. (2025) · Cellular Signalling · doi:10.1016/j.cellsig.2025.111906 · Cited by 9
State of the Art in Novel Treatment Strategies in Rheumatoid Arthritis: A Brief Review
Nascimento, M. M. P., Azuelos, A., Nóbrega, I. L. P., Pitombeira, M. S., Martinez, A. T. A., de Carvalho, J. F., & Rodrigues, C. E. M. (2025) · Mediterranean Journal of Rheumatology · doi:10.31138/mjr.241124.ath · Cited by 12
Neurotrophic factors in multiple sclerosis
Güner, F., & Rothhammer, V. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1654603 · Cited by 10
Noticeable immune dysregulation-and-suppression in parvovirus affected dogs
Asil, M. S., Zarifian, N., Valafar, A., Shirani, D., & Mehrzad, J. (2023) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2023.110663 · Cited by 9
Zhao, X., Dai, R., Wang, J., Liangliang, C., Chen, P., Yao, W., Cheng, F.-F., Bao, B., & Li, Z. (2023) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2023.115853 · Cited by 9
Wang, T., Zhang, X., Liu, W., Ning, F., Hu, X., Qin, L., Cui, M., Yang, J., Lv, S., & Wang, Q. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2023.1335512 · Cited by 13
de Souza, I. R., Iulini, M., Galbiati, V., Rodrigues, A. C., Gradia, D. F., Martino‐Andrade, A. J., Firman, J. W., Pestana, C. B., Leme, D. M., & Corsini, E. (2024) · Archives of Toxicology · doi:10.1007/s00204-024-03738-x · Cited by 9
Liu, H., Qiu, L., Li, H., Tang, Y., Wang, F., Song, Y., Pan, Y., Li, R., & Yan, X. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.134427 · Cited by 9
Berdeville, C. H. D. S. F., Silva-Amaral, D., Dalgalarrondo, P., Banzato, C. E. M., & Martins‐de‐Souza, D. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105949 · Cited by 10
Inflammation in Penile Squamous Cell Carcinoma: A Comprehensive Review
Czajkowski, M., Wierzbicki, P., Dolny, M., Matuszewski, M., & Hakenberg, O. W. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26062785 · Cited by 10
Yan, Y., Dong, R., Zhang, C., & Jiang, Q. (2021) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2021.12.039 · Cited by 9
Keller, L. E., Fortier, L. A., Lattermann, C. M., Hunt, E. R., Zhang, S., Fu, Q., & Jacobs, C. A. (2023) · Journal of Cartilage & Joint Preservation · doi:10.1016/j.jcjp.2023.100114 · Cited by 9
Wang, S., Jiang, J.-H., Liu, S., Zhang, J., Gao, X. Y., Liu, H., Ke, K.-X., Jiang, Y., Liu, L., & He, B. (2023) · Aging · doi:10.18632/aging.204504 · Cited by 9
Pre-treatment with IL-6 potentiates β-cell death induced by pro-inflammatory cytokines
Oliveira, V. R. D., de Paula, C. C., Taniguchi, S., & Ortis, F. (2023) · BMC Molecular and Cell Biology · doi:10.1186/s12860-023-00476-3 · Cited by 12
Ma, X., Xia, K., Xie, J., Yan, B., Han, X., Li, S., Wang, Y., & Fu, T. (2023) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.3c00033 · Cited by 11
Ren, K., Wang, L., Wang, Y., An, G., Du, Q.-X., Cao, J., Jin, Q., Yun, K., Guo, Z., Wang, Y., et al. (2022) · Forensic Science International Genetics · doi:10.1016/j.fsigen.2022.102722 · Cited by 9
Lian, S., Su, J., Fatima, I., Zhang, Y., Kuang, T., Hu, H., Qu, D., Si, H., & Sun, W. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.134532 · Cited by 8
Mazurek−Mochol, M., Bonsmann, T., Malinowski, D., Serwin, K., Czerewaty, M., Safranow, K., & Pawlik, A. (2024) · Microorganisms · doi:10.3390/microorganisms12101954 · Cited by 9
Júnior, P. A. M., Dias, M. S. S., de Souza, A. B. F., Lopes, L. S. E., Menezes, T. P., Talvani, A., Brochard, L. J., & Bezerra, F. S. (2024) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2024.104361 · Cited by 8
Zhang, Y., Li, R., Chen, X., Li, Y., Zhang, Q., Yang, L., Wang, L., Sun, Y., Mao, F., & Zhuo, C. (2025) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70206 · Cited by 8
Sabe, H., Inoue, A., Nagata, S., Imura, Y., Wakamatsu, T., Takenaka, S., & Tamiya, H. (2021) · Case Reports in Oncological Medicine · doi:10.1155/2021/5532258 · Cited by 8
Recent advances of bioactive proteins/polypeptides in the treatment of breast cancer
Li, Q., Zhou, Z., Hu, C., Li, X., Chang, Y., Liu, Y., Wang, Y., & Zhou, X. (2023) · Food Science and Biotechnology · doi:10.1007/s10068-022-01233-6 · Cited by 9
Tocilizumab (monoclonal anti-IL-6R antibody) reverses anlotinib resistance in osteosarcoma
Xu, J., Chen, C., Sun, K., Shi, Q., Wang, B., Huang, Y., Ren, T., & Tang, X. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1192472 · Cited by 10
Xie, C., Chen, X., Chen, Y., Wang, X., Zuo, J., Zheng, A., Luo, Z., Cheng, X., Zhong, S., Jiang, J., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06307-9 · Cited by 8
Adumitrăchioaiei, H., Săsăran, M. O., & Mărginean, C. O. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147655 · Cited by 9
Thakur, N., Pandey, R. K., & Mehrotra, S. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06586-5 · Cited by 9
Biological Actions of Bile Acids via Cell Surface Receptors
Kiriyama, Y., Tokumaru, H., Sadamoto, H., & Nochi, H. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26115004 · Cited by 8
Wei, L., Wu, H., Li, W., Chen, M., Cui, B., Wang, X., Wu, T., & Cheng, Y. (2025) · Food & Function · doi:10.1039/d5fo01536g · Cited by 9
Plasma Proteomics Reveals Biomarkers and Undulating Changes in Metabolic Aging
Zhang, J., Yu, H., Xiong, Y., Xue, D., Chen, S., Li, J., Li, X., Xie, J., Wang, Y., Xu, K., et al. (2025) · Research · doi:10.34133/research.1004 · Cited by 10
Duan, Y., Ou, Y., Li, J., Gan, X., & Cao, J. J. (2025) · The Italian Journal of Pediatrics/Italian journal of pediatrics · doi:10.1186/s13052-025-02012-9 · Cited by 7
Zhang, H., Li, G., Ni, L., Wang, R., Peng, L., Zang, L., Lu, C., Wang, Z., & Liu, J. (2025) · Scientific Reports · doi:10.1038/s41598-025-11480-2 · Cited by 7
Ren, J.-X., Gao, Q., Zhou, X.-C., Chen, L., Guo, W., Feng, K., Lü, L., Huang, T., & Cai, Y. (2023) · Biology · doi:10.3390/biology12070947 · Cited by 7
Immunosuppressive effects of the mycotoxin patulin in macrophages
de Sales-Neto, J. M., & Rodrigues‐Mascarenhas, S. (2024) · Archives of Microbiology · doi:10.1007/s00203-024-03928-2 · Cited by 7
Роль адипокинов в формировании кардиометаболических нарушений у человека
Игоревна, А. В., & Mustafina, S. V. (2023) · Ateroscleroz · doi:10.52727/2078-256x-2022-18-4-388-394 · Cited by 7
Acupuncture Treats Sepsis through Immune Modulation and Organ Protection
Wang, Z.-X., Qin, R.-J., Yu, L., Nurlan, A., Jing, X., & Li, M. (2024) · Current Medical Science · doi:10.1007/s11596-024-2957-0 · Cited by 6
Peng, Y., Liu, C., Liu, W., & Gan, R. (2024) · International Journal of Medical Sciences · doi:10.7150/ijms.104928 · Cited by 6
Liu, J., Xia, W., Cheng, J., Geng, Y., Li, W., & Fan, Y. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1585020 · Cited by 7
Oliver, M. A., Alward, K. J., Rhoads, M. L., & Ealy, A. D. (2025) · Animals · doi:10.3390/ani15050668 · Cited by 6
Understanding the immune profile of sudden infant death syndrome – proteomic perspectives
Ferrante, L., Opdal, S. H., & Byard, R. W. (2023) · Acta Paediatrica · doi:10.1111/apa.16988 · Cited by 6
Jin, P., Jin, X., He, L., Liu, W., & Zhan, Z. (2024) · Clinical and Experimental Medicine · doi:10.1007/s10238-024-01327-x · Cited by 6
Ren, J., Zhang, Z., Li, R., Tian, H., Guo, Z., Xue, W., Zhang, Y., Chen, F., Deng, Y., & Ma, Y. (2024) · Environmental Science and Pollution Research · doi:10.1007/s11356-024-33414-7 · Cited by 5
He, Y., Zhou, H., Qu, Y., Chi, R., Xu, H., Chen, S., Meng, C., Liu, Q., Huang, X., You, H., et al. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116370 · Cited by 5
Yang, X., Wang, X., & Yang, J. (2025) · Archives of Dermatological Research · doi:10.1007/s00403-025-03894-9 · Cited by 5
Cao, Y. Z., Xiao, S., He, B., Shi, X., Xiao, N., Liu, X., Liu, D., Zhou, Z., & Wang, P. (2025) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5c02749 · Cited by 5
Metadata
- Authors
- Kang, S., Narazaki, M., Metwally, H., & Kishimoto, T.
- Affiliations
- Immunology Frontier Research Center, The University of Osaka (JP)
- The University of Osaka (JP)
- Corresponding author
- Kishimoto, Tadamitsu
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2020-04-08
- Volume
- 217
- Issue
- 5
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC7201933
- OpenAlex
- W3014527183
- Cited by
- 360
- References
- 105
- Citations by year
- 2026: 25 · 2025: 96 · 2024: 76 · 2023: 72 · 2022: 49 · 2021: 33 · 2020: 9
- FWCI
- 4.37
- Type
- journal article
- Language
- en
- Update notices
- correction (2020-04-27)
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Journal of Experimental Medicine (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Funders
- Ministry of Education, Culture, Sports, Science and Technology (17K15722, 17K10002)
- Astellas Foundation for Research on Metabolic Disorders
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Keywords
- interleukin-6, IL-6 family cytokines, gp130, IL-6 receptor, IL-6 signaling, IL-6 inhibitors, B cell antibody production
- MeSH terms
- Animals, Humans, Models, Biological, Mutation, Interleukin-6, Receptors, Interleukin-6, MicroRNAs, History, 20th Century, Genetic Pleiotropy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.